Angeles Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-380
Closed -$202K 231
2023
Q4
$202K Buy
+380
New +$184K 0.01% 185
2022
Q4
Sell
-435
Closed -$221K 116
2022
Q3
$221K Sell
435
-15
-3% -$8.39K 0.02% 39
2022
Q2
$244K Buy
450
+55
+14% +$30.3K 0.02% 88
2022
Q1
$233K Sell
395
-5,582
-93% -$3.21M 0.02% 107
2021
Q4
$3.99M Buy
5,977
+582
+11% +$363K 0.2% 35
2021
Q3
$3.08M Buy
5,395
+1,833
+51% +$1.01M 0.18% 39
2021
Q2
$1.8M Sell
3,562
-575
-14% -$271K 0.11% 38
2021
Q1
$1.89M Buy
4,137
+80
+2% +$38.2K 0.15% 29
2020
Q4
$1.89M Buy
4,057
+205
+5% +$96.1K 0.19% 24
2020
Q3
$1.7M Buy
3,852
+370
+11% +$153K 0.21% 23
2020
Q2
$1.26M Sell
3,482
-542
-13% -$182K 0.18% 27
2020
Q1
$1.33M Buy
4,024
+844
+27% +$266K 0.36% 22
2019
Q4
$1.03M Buy
3,180
+299
+10% +$90.7K 0.21% 30
2019
Q3
$839K Buy
2,881
+1,820
+172% +$521K 0.18% 32
2019
Q2
$312K Buy
+1,061
New +$292K 0.08% 50

Other funds holding TMO

Angeles Investment Advisors's TMO Position: Q1 2024 in Review

Angeles Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 380 shares — an estimated $202K sold.

Angeles Investment Advisors first reported a position in TMO in Q2 2019 and held it in 15 quarters. The position peaked at $3.99M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Angeles Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Angeles Investment Advisors sold 380 Thermo Fisher Scientific shares in Q1 2024, an estimated $202K.
  • Angeles Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 15 quarters.
  • Angeles Investment Advisors's Thermo Fisher Scientific position peaked at $3.99M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Angeles Investment Advisors's 13F filing for Q1 2024, filed 14 May 2024.